1. Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10. Issue 2 (March 2019) Authors: Kienle, Dirk L.; Dietrich, Daniel; Ribi, Karin; Wicki, Andreas; Quagliata, Luca; Winterhalder, Ralph C.; Koeberle, Dieter; Horber, Daniel; Bastian, Sara; Kueng, Marc; Saletti, Piercarlo; Helbling, Daniel; Baertschi, Daniela; Lugli, Alessandro; Bernhard, Juerg; Andrieu, Christiane; von Moos, Roger Journal: Journal of geriatric oncology Issue: Volume 10:Issue 2(2019) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13). (June 2018) Authors: Wicki, Andreas; Brown, Nicholas; Xyrafas, Alexandros; Bize, Vincent; Hawle, Hanne; Berardi, Simona; Cmiljanović, Nataša; Cmiljanović, Vladimir; Stumm, Michael; Dimitrijević, Saša; Herrmann, Richard; Prêtre, Vincent; Ritschard, Reto; Tzankov, Alexandar; Hess, Viviane; Childs, Alexa; Hierro, Cinta;... Journal: European journal of cancer Issue: Volume 96(2018) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Grover's-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy. Issue 1 (16th August 2016) Authors: Koelzer, Viktor H.; Buser, Tobias; Willi, Niels; Rothschild, Sacha I.; Wicki, Andreas; Schiller, Peter; Cathomas, Gieri; Zippelius, Alfred; Mertz, Kirsten D. Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Grover's-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy. Issue 1 (December 2016) Authors: Koelzer, Viktor; Buser, Tobias; Willi, Niels; Rothschild, Sacha; Wicki, Andreas; Schiller, Peter; Cathomas, Gieri; Zippelius, Alfred; Mertz, Kirsten Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Inhibition of Akt and other AGC kinases: A target for clinical cancer therapy?. (February 2018) Authors: Prêtre, Vincent; Wicki, Andreas Journal: Seminars in cancer biology Issue: Volume 48(2018) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards. (January 2023) Authors: Christ, Sebastian M.; Heesen, Philip; Muehlematter, Urs J.; Pohl, Kaspar; William Thiel, Gabriel; Willmann, Jonas; Ahmadsei, Maiwand; Kroese, Tiuri E.; Mayinger, Michael; Balermpas, Panagiotis; Wicki, Andreas; Andratschke, Nicolaus; Huellner, Martin; Guckenberger, Matthias Journal: Clinical and translational radiation oncology Issue: Volume 38(2023) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy. (1st January 2020) Authors: Rentsch, Cyrill A.; Bosshard, Piet; Mayor, Grégoire; Rieken, Malte; Püschel, Heike; Wirth, Grégory; Cathomas, Richard; Parzmair, Gerald P.; Grode, Leander; Eisele, Bernd; Sharma, Hitt; Gupta, Manish; Gairola, Sunil; Shaligram, Umesh; Goldenberger, Daniel; Spertini, François; Audran, Régine; Enoiu... Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial. Issue 1 (December 2016) Authors: Rochlitz, Christoph; Bigler, Martin; von Moos, Roger; Bernhard, Jürg; Matter-Walstra, Klazien; Wicki, Andreas; Zaman, Khalil; Anchisi, Sandro; Küng, Marc; Na, Kyung-Jae; Bärtschi, Daniela; Borner, Markus; Rordorf, Tamara; Rauch, Daniel; Müller, Andreas; Ruhstaller, Thomas; Vetter, Marcus; Trojan,... Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Simulating urban climate at sub‐kilometre scale for representing the intra‐urban variability of Zurich, Switzerland. (29th July 2019) Authors: Mussetti, Gianluca; Brunner, Dominik; Allegrini, Jonas; Wicki, Andreas; Schubert, Sebastian; Carmeliet, Jan Journal: International journal of climatology Issue: Volume 40:Number 1(2020) Page Start: 458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy. (2nd January 2016) Authors: Orleth, Annette; Mamot, Christoph; Rochlitz, Christoph; Ritschard, Reto; Alitalo, Kari; Christofori, Gerhard; Wicki, Andreas Journal: Journal of drug targeting Issue: Volume 24:Number 1(2016) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗